LGND
Ligand Pharma (LGND)
NASDAQ
$286.55+$2.08 (+0.73%)
Price as of Sep 11, 2026 7:58 PM EDT
  • $5.7B
    Market Cap
  • 71.63%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
TUDOR INVESTMENT CORP ET AL
78.59%
15.8M
+15.8M (+100.00%)
Sep 30, 2025
BLACKROCK, INC.
15.47%
3.1M
+139,073 (+4.48%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
14.70%
2.9M
-53,548 (-1.82%)
Dec 31, 2024
BLACKROCK INC.
14.33%
2.9M
+3,226 (+0.11%)
Jun 30, 2024
VANGUARD GROUP INC
10.35%
2.1M
-2,391 (-0.12%)
Dec 31, 2025
BLACKROCK FUND ADVISORS
8.85%
1.8M
+187,911 (+10.60%)
Dec 31, 2016
INVESCO LTD.
6.00%
1.2M
+378,040 (+31.46%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions355.4M (51.79%)
  • Mutual Funds326.6M (47.58%)
  • Insiders4.3M (0.63%)
  • Other0 (0.00%)

Insider Transactions

  • 0.63% (4.3M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 8
    Number of InsiderSelling (last 12 months)
  • $876.9M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$85,195.62
300
$283.99
41,214
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$513,300.78
1,800
$285.17
39,414
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$605,649.07
2,115
$286.36
37,299
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$110,697.24
385
$287.53
36,914
Reardon Andrew
CLO & Secretary
Sell
Sep 03, 2026
$115,591.68
400
$288.98
36,514
Haas Jason
Exempt
Aug 12, 2026
$0.00
6,138
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
2,869
$0.00
0
Haas Jason
Exempt
Aug 12, 2026
$316,475.28
6,138
$51.56
11,119
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
7,171
$0.00
0
Haas Jason
Sell
Aug 12, 2026
$2.1M
7,138
$292.81
3,981
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
16,179
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
3,348
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$0.00
2,074
$0.00
0
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$854,898.36
16,179
$52.84
43,875
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$145,262.96
2,074
$70.04
45,949
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$159,946.75
2,869
$55.75
48,818
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$410,324.62
7,171
$57.22
55,989
Espinoza Octavio
Chief Financial Officer
Exempt
Aug 12, 2026
$230,141.52
3,348
$68.74
59,337
Espinoza Octavio
Chief Financial Officer
Sell
Aug 12, 2026
$9.2M
31,641
$292.06
27,696
Reardon Andrew
CLO & Secretary
Exempt
Aug 03, 2026
$0.00
5,000
$0.00
29,444
Reardon Andrew
CLO & Secretary
Exempt
Aug 03, 2026
$261,350.00
5,000
$52.27
46,514
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$29,834.44
105
$284.14
46,409
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$9,390.25
33
$284.55
46,376
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$44,860.50
157
$285.74
46,219
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$295,974.30
1,032
$286.80
45,187
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$349,356.54
1,214
$287.77
43,973
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$102,794.86
356
$288.75
43,617
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$145,770.51
503
$289.80
43,114
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$58,120.00
200
$290.60
42,914
Reardon Andrew
CLO & Secretary
Sell
Aug 03, 2026
$289,086.49
991
$291.71
41,923